Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$6,000,000.00
Apr 1, 2022
Individual or sole proprietorship
Canadian Immunization Research Network (CIRN): Funding Extension
162588
The objectives of the extension are aligned with the Canadian Immunization Research Network (CIRN) 2016 and the CIRN: COVID-19 Vaccine Readiness are:
• To maintain the baseline activities of CIRN. This includes support for its infrastructure of networks to facilitate collaborative research among vaccine and immunization researchers, clinicians, public health professionals and policy makers.
• To support CIRN’s COVID-19 activities related to critical research in the research areas of the COVID-19 Vaccine Readiness grant (vaccine clinical trials [incl. vaccine safety and effectiveness studies]; population prioritization and modelling; vaccine hesitancy and uptake; and coordination and information sharing. The research activities within these research areas will address the evolving COVID-19 vaccine research needs of Canada, and will provide vaccine-related research outcomes to inform effective, equitable and timely COVID-19 public health decision-making .
$49,992.00
Apr 1, 2022
For-profit organization
DNA Vaccine Platform Development
988568
Pegasus Biotech is developing a DNA vaccine development platform to provide accelerated vaccine development services to new and existing clients.
$0.00
Mar 17, 2022
Not-for-profit organization or charity
Vaccin humain contre l'isolement
018197152
The objectives of the Program are: .• promoting volunteerism among seniors; .• engaging seniors in the community through.mentoring of others; .• expanding awareness of elder abuse, including.financial abuse; .• supporting social participation and inclusion of.seniors; and .• providing capital assistance for new and existing.community projects and/or programs for seniors. .
$79,400,000.00
Mar 17, 2022
Academia
000021039
000021039
Establish a National Centre for Pandemic Research
$46,200,000.00
Mar 17, 2022
Academia
000021039
000021039
Establish a National Centre for Pandemic Research
$46,200,000.00
Mar 17, 2022
Academia
000021039
000021039
Establish a National Centre for Pandemic Research
$76,200,000.00
Mar 17, 2022
Academia
000021039
000021039
Establish a National Centre for Pandemic Research
$76,200,000.00
Mar 17, 2022
Academia
000021039
000021039
Establish a National Centre for Pandemic Research
$908,799.00
Mar 8, 2022
Government
Agreement for the Development of Mandatory Entry Level Training Virtual Reality Simulator for Class 1 Novice Commercial Drivers to Improve Road Safety - Phase 1
164295
To develop and improve technology to promote a safer road transportation system To support education and training to improve the safety of roadways road users and motor vehicles To undertake research activities to further public policy development revise non-federal safety regulations etc
$6,700,000.00
Mar 1, 2022
Individual or sole proprietorship
Op. Grant: Canadian Pediatric COVID-19 Research Platform
164785
To be eligible to the competition, applications must address ALL objectives AND key design components:
• Establish central coordination and collaboration activities with Collaborating Sites located across Canada to increase the availability of high-quality and real-time evidence to support research on the effectiveness and relative safety of the COVID-19 vaccines in children and youth;
• Generate research evidence related to COVID infection and vaccination in diverse children and youth population(s), including (but not limited to):
o Equity considerations;
o Health and well-being status (e.g., historically excluded or underserved populations, individuals with complex health needs and/or a disability);
o Sex and gender; and/or
o Racialized and Indigenous (First Nations, Inuit, Métis and Urban Indigenous) populations.
• Identify children and youth populations at the highest and high risk for negative outcomes related to COVID-19 vaccination, and other determinant of health factors (e.g., social, economic, behaviour, etc.) that are associated with this increased greater risk.
• Harmonize data collection, and improve open and real-world data sharing with relevant knowledge-users in an accessible, useful and relevant format to support a timely and effective COVID-19 public health response within and across all jurisdictions in Canada as it relates to children and youth;
• Collaborate across Sites to establish resource and data sharing policies, increase efficiencies in research and related processes (including but not limited to ethics review; privacy considerations; contracts; informed-consent; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research and surveillance activities related to COVID-19 vaccination of children and youth; and
• Provide research evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and all across jurisdictions in Canada and internationally.